A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

AAOS Partners with J3P Healthcare Solutions

Aaos

The American Academy of Orthopaedic Surgeons (AAOS) kicks off a three-year partnership with J3P Healthcare Solutions this summer, as part of the organizations’ ongoing commitment to leadership development.

Through the partnership, AAOS will further customize the AAOS Leadership Institute (ALI), a self-paced program, building the pipeline for AAOS’ future leaders.  Offered to members in four successive tiers, the program provides leadership training, mentorship and networking opportunities to members seeking to acquire and refine the skills needed to progress as a successful volunteer leader at AAOS.

The ALI program begins with Levels 1 and 2 as foundational learning, with access available to all members, to orient them into AAOS’ culture and prepare them for AAOS committee service. ALI Levels 3 and 4 are built around refined skills like change leadership and team effectiveness. The J3P leadership tools and the interactive sessions led by J3P’s expert consultants will augment the Level 3 and 4 program components with additional personalized leadership education and experiential learning.

“The opportunity to bring in a dedicated partner like J3P who is so versatile and experienced in physician leadership is very exciting,” said Joseph A. Bosco, III, MD, FAAOS, AAOS past president. “This hands-on program is about developing a personalized and differentiated learning experience for our potential future volunteers that will expand their unique leadership capacity through self-awareness, as the complexities and scope of leadership are dynamic and quite personal in nature.”

J3P will host the first in-person workshop for participants in ALI Level 4 in San Diego, during the AAOS 2021 Annual Meeting taking place August 31 – September 3, 2021. Participants will complete a proprietary Healthcare Professional Success Assessment, receive a confidential reporting package including an individualized mentor guide and have a one-on-one virtual debrief with one of J3P’s expert coaches.

“Our customized roadmap for this hands-on program is grounded in individual and organizational science, and is built around the specific, current needs of orthopaedic surgeons, and the AAOS as an organization,” said Alan Friedman, MA, founder and CEO, J3P Healthcare Solutions. “Together, we will create the foundation for current and future AAOS leaders to be more effective in their volunteer roles and better equip them with communication, listening, team building and other vital leadership skills.”

ALI Level 3 participants also will take part in an assessment, have access to a digital development platform and shared group leadership coaching. AAOS Members can begin ALI Level 1 at any time and should visit aaos.org/leadershipinstitute for more information.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy